Sichuan Kelun Pharmaceutical financials at a glance

+ Portfolio

The revenue of Sichuan Kelun Pharmaceutical is reported as 21.45393 billion Yuan Renminbi in the fiscal year 2023. The earnings were 1.57 Yuan Renminbi per share in 2023, which was 256.82 higher than 2020. And about 5.33707 billion Yuan Renminbi are reported as free cash flow in the financials of Sichuan Kelun Pharmaceutical 2023. Dividends of 0.8 Yuan Renminbi per share were paid to shareholders of Sichuan Kelun Pharmaceutical stock SZSE:002422 in fiscal 2023.

¥21.45B

Revenue

¥1.57

Earnings Per Share

100.00%

Gross Margin %

¥1.37B

Free Cash Flow

Revenue

21,453.93

Earnings Per Share

1.57

Gross Margin %

100.00

Free Cash Flow

1,365.84

Financials

Year	Year	TTM	2023	2020	2019	2018	2017	2014	2013	2012	2011	2010
Rev.	Revenue	N/A	¥21.45B	¥16.46B	¥17.64B	¥16.35B	¥11.43B	¥8.02B	¥6.83B	¥0.00M	¥5.15B	¥4.03B
GM %	Gross Margin %	51.50%	100.00%	53.96%	59.95%	59.16%	50.65%	41.07%	44.59%	41.81%	42.02%	39.88%
OM	Operating Margin	13.50%	17.03%	9.33%	8.47%	11.18%	9.90%	17.64%	21.29%	21.01%	20.87%	18.93%
EPS	Earnings Per Share	¥1.48	¥1.57	¥0.44	¥0.55	¥0.78	¥0.52	¥0.64	¥0.75	¥0.67	¥0.64	¥0.51
Div.	Dividends	N/A	¥0.80	¥0.32	¥0.43	¥0.21	¥0.21	¥0.13	¥0.08	¥0.00	¥0.08	¥0.00
PR %	Payout Ratio %	0	50.96%	72.73%	78.18%	26.92%	40.38%	20.31%	10.67%	0	12.50%	0
Sha.	Shares	N/AM	1,451.34M	1,430.18M	1,439.79M	1,439.85M	1,440M	1,440M	1,440M	1,440M	1,440M	1,440M
OCF	Operating Cash Flow	N/A	¥5.34B	¥2.22B	¥2.22B	¥2.95B	¥1.10B	¥0.00M	¥1.05B	¥0.00M	¥342.93M	¥149.29M
FCF	Free Cash Flow	N/A	¥1.37B	¥988.50M	¥885.70M	¥1.62B	¥-,475.32M	¥0.00M	¥-1,208.48M	¥0.00M	¥-1,661.73M	¥-,497.93M
FCFS	Free Cash Flow Per Share	¥2.90	¥0.00	¥0.70	¥0.62	¥1.14	¥-0.26	¥-1.07	¥-0.84	¥-1.65	¥-1.15	¥-0.39

Sichuan Kelun Pharmaceutical financials at a glance

Financials

Discover